Company intelligence / Profile preview
Unique Biotech
- Ownership
- Private
- Development stage
- Commercial
Overview
Unique Biotech has over two decades of experience in developing and manufacturing clinically proven probiotics. Their products are supported by preclinical and clinical studies, with several proprietary strains having US FDA GRAS status. They supply globally to food, supplement, pharmaceutical, animal healthcare industries; their probiotics are documented for safety and efficacy[1][2][4].
- Therapeutic areas
- GastroenterologyImmunology
- Modalities
- Live biotherapeutic product therapyEnzyme replacement therapyNutraceuticals
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Unique Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Unique Biotech.